Here, we not only show a case of complete remission of metastatic melanoma after treatment with pembrolizumab in a HIV-1-infected individual, but also an enhancement of T-cell activation and the HIV-1 specific-CD8+ T-cell response. This evidence concerns the gene CD8A and metastatic melanoma.